Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Investors & Dealmaking

Digital Edition: MedTech Strategist July-August 2026

Stuart Essig speaks about his return to the CEO role at Integra LifeSciences; the AUA's Innovation Nexus is driving investor interest in the urology market; at NASS, the many challenges of selling innovative technologies into the healthcare system; Magenta Medical takes on Abiomed in cardiogenic shock; XVIVO's novel transport device could expand the viability timeframe in heart transplant; and profiles of Signum Surgical and Square Mind.

Read Article